Simon Mooijaart

The Most Common Kind of Cancer Patient in America Is the One We Study the Least At 82, would former President Joe Biden even qualify for the trials he funded?

Well said. Not including older adults in research studies about diseases that primarily affect older adults is just ageism, pure and simple.
slate.com/technology/2...

Incredible evening launching @acha020.bsky.social having a peek into the amazing research and community work for the population of East London planned with the fabulous @proflizsampson.bsky.social & @adamgordon1978.bsky.social

t.co/WCgXPtK7Vc

☑️ The original CAM does work when used by trained raters

‼️ But an unvalidated CAM variant - with no cognitive testing/interview - is widely used in clinical practice

⚠️ This 'CAM-Lite' has dangerously low sensitivity

➡️ New blog on this critical issue in #delirium care

Link below⏬

🥳 Superproud of this bunch: the management team of the CoClarity #RCT. Submitted the trial protocol today.

#CoClarity: A Shared Decision Support Tool to reconsider the use of Anti-Thrombotic Therapy in patients with #cancer in the last phase of life:

✅ Lower risk of #thrombosis
🛑 Risk of bleeding

Very nice #thesis defense by Jonathan Bogaerts earlie this week. 🧑🏻‍🎓

Depresribing of antihypertensive medication in the very old, an inspiring topic for lively (and funny) discussion!

🥳 Congratulations, Jonathan!

#geriatrics #hypertension #medsky

Shared Opportunities and Challenges – ACHA forges a research collaboration with the LUMC Centre for Medicine for Older People - Academic Centre for Healthy Ageing

The latest in our @acha020.bsky.social blog series - Shared Opportunities and Challenges - ACHA forges a research collaboration with the LUMC Centre for Medicine for Older People.

@wilcoachterberg.bsky.social @drsimonpm.bsky.social @proflizsampson.bsky.social

acha.qmul.ac.uk/research/sha...

So inspiring! Looking forward to your return visit already 😀

Use of #AI decreases with increasing age.

✅ #AI offers a lot of promises also in care for older people
❌ #AI is not tailored to needs of older people

➡️ We have work to do

🔗 JAMA, buff.ly/2jxuUhz

#geriatrics #digital #medsky

Very nice #thesis by Jonathan Bogaerts:

📓 High blood pressure and its treatment in the very old - balancing benefits and risks
🧑‍🎓 Defense April 16th at #Leiden University

😀 really looking forward

#geriatrics #hypertension #medsky

Nice presentation by #PhD candidate Denise Abbel about the complex choice to use #antithrombotic therapy in patients with #cancer in the last phase of life:

✅ prevention of thrombic events
❌ risk of bleeding

❓what is more important?

#oncology #geriatrics

Interesting! Can you share a link please?

Nice hike 🥾 exploring the surroundings of the Symposium 😀

Signing in at the European #Pancreas Islet Transplantation Association Symposium for a talk tomorrow on #transplantation in older people

📍Igls, Innsbruck, #Austria

#geriatrics

🥳 Kudos to Eva Kempers!

📝 Our study in #Thrombosis and #Haemostasis explores anticoagulant use in life-limiting diseases

➡️ most patients continued until end-of-life with comparable risks of bleeding or clots after stopping

🔗 10.1055/a-2524-5334

#palliativecare #geriatrics

Systemic treatment among frail older patients with cancer: An observational cohort In the past, certain oncological therapies were not offered to frail older patients. However, the advancement of geriatric oncology, tailored chemotherapy regimens, the introduction of new treatments, and the optimization of supportive care have contributed to enhancing the therapeutic margin. We aimed to evaluate the benefit of systemic treatment among older adults by assessing the three-month survival of older frail patients with metastatic cancer.

🚨 Excited to share our work : "Systemic treatment among frail older patients with cancer".
✅ 3-month OS 81.8% when guided by geriatric assessments.
⚠️ Loss of ADL and cumulative frailty factors associated with poorer survival

🔗https://www.geriatriconcology.net/article/S1879-4068(24)00450-8/abstract

Figure: Randomised controlled trials of artificial intelligence in clinical practice across countries and specialties. Copyright: 2024 The Author(s). Open Access under CC BY-NC-ND 4.0 license

Artificial intelligence (AI) in health care has seen remarkable growth.

What is the potential of AI to improve care management, clinical decision-making efficiency, and more?

📑 Read this Review in The Lancet Digital Health: bit.ly/3DwAJtD

On "Face Age"
>300,000 people have taken Novos free #AI test
(a company that sells longevity kits & supplements) without published data
wsj.com/health/welln...

"People who use face-age tests to estimate their biological age should take the results with a grain of salt"
@andrewlbeam.bsky.social

Attitudes of medical researchers towards #AI #chatbots:

✳️ interested
❓ more training needed

Nice study in The Lancet Digital Health!

🔗 https://buff.ly/4gwhLSK

#medsky

Performance Assessment of GPT 4.0 on the Japanese Medical Licensing Examination - Current Medical Science Objective To evaluate the accuracy and parsing ability of GPT 4.0 for Japanese medical practitioner qualification examinations in a multidimensional way to investigate its response accuracy and…

#ChatGPT passes Japanese #Medical Licensing #Exam

✅ The correct response rate reached the qualification level
❓Performance varied by year / question type

➡ My take: development needed (medical #LLM), but soon will pas with flying colors

40% of ED attendances are over 65yrs. Average wait for admission in>75yrs =12 hours. 10% attendances from care homes. Waiting is especially bad for older -risk of delirium, deconditioning, acute kidney injury/LOS. But much could be done to avoid these probs @gerisoc.bsky.social @rcem.bsky.social

Older AI (LLM) on the brink of needing a nursing home…! Maybe it’s time we start thinking about digital elder care! 😉

Sunday afternoon ride on Traning Peaks Virtual 🚴‍♂️

#cycling #TPV

🔗 http://tpks.ws/IMLFGMTKUIJKNWYA2WCXJGA5WY

🌧️ 💨 ☁️ Typical depressingly grey, cloudy, windy and rainy weather on the shortest day of the year 🌧️ 💨 ☁️

BUT:

☀️ 😎 longer days, more light and more sun from today onwards ☀️ 😎

Why later life can be a golden age for friendship Our social goals change in surprising ways over our lifespan – and understanding this can help us build fulfilling connections with others, research suggests.

To think about during this Holiday Season:

“… encounters with #friends were seen as more pleasant than with #family”… 😳

I will be enjoying both myself 😀

Why later life can be a golden age for friendship

The link between physical inactivity and accelerated brain aging

alz-journals.onlinelibrary.wiley.com/doi/full/10....

🤩 Very excited and proud to have received the #PhD #thesis of Carlijn Voorend

📖 Appropriate care for older people approaching #kidney failure. Design and implementation of geriatric assessment in kidney care

👩‍🎓 Looking forward to the defense on January 27th !

#geriatrcs #nephrology #gerisky

✳️ Exciting day for the LUMC #Research Theme on #Lifecourse #Epidemiology and #Geroscience on January 27th 2025.

🤩 Looking forward to a lot of inspiration by our talented #PhD and #Postdoc researchers!

#geriatrics

Semantics or not?

I would say: in this study, #statins did not “improve” survival, but “statin usee associated with better survival compares to non-statin use”.

➡️ “Improves” to me suggests it became better over time, which suggests effectiveness of intervention.

❓What do you think?